Safety Analyses of the Phase 3 VISION Trial of [(177)Lu]Lu-PSMA-617 in Patients with Metastatic Castration-resistant Prostate Cancer
Publication Date
2024
Content Type
Article
PubMed ID:
Citation
European Urology (2024) 85(4):382-391
2024
Article
European Urology (2024) 85(4):382-391